HOME >> BIOLOGY >> NEWS
2007 Joint Assembly in Acapulco -- press conference schedule

ities greater than 10 million inhabitants) are multiplying, particularly in South America, Asia, and other parts of the developing world. By pumping pollutants into the atmosphere, these hubs of industrial activity and intensive motor-vehicle use cause local, regional, and global effects that are coming into focus as a result of targeted scientific investigations. In this press conference, panelists will discuss some key results from major field studies conducted in Mexico City and So Paulo, Brazil. Among the highlights, scientists find that the chemistry of emissions from developing megacities differs from what's brewing over established megacities, particularly with regard to aerosols important to climate change and health.

Participants

  • Luisa T. Molina: Principal Research Scientist, Department of Earth Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; Director, Molina Center for Energy and the Environment (MCE2) Lead scientist, MCMA-2006 /MILAGRO;
  • Jeffrey S. Gaffney: Chair and Professor, Department of Chemistry University of Arkansas, Little Rock, Arkansas, USA; Lead Scientist, MAX-Mex/MILAGRO;
  • Paulo Artaxo: Institute of Physics, University of So Paulo, Rua do Mato, Travessa R, 187 So Paulo, SP, Brazil; Member, Global Air Pollution Forum.

Session: A23C


Tuesday, 22 May
1400h

Keeping Track of Earth's Slippers

One of the great geophysical advances in the last decade has been the development of Global Positioning System (GPS) receivers as tools for directly measuring plate tectonics. Using networks of GPS receivers that routinely gauge deformation in plate boundary zones around the world, scientists find that plates don't just creep along at a steady pace. Rather, they sometimes suddenly speed up or even change directionactions known as slow slip events (SSE) or transient deformation. Nowhere are SSEs more dramat
'"/>

Contact: Peter Weiss
pweiss@agu.org
202-777-7507
American Geophysical Union
18-May-2007


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. National Ecological Observatory Network featured at ESA/SER Joint International Conference
2. DOE Joint Genome Institute secures long-term lease on production genomics facility
3. Joint research on poverty-related diseases
4. Latest advances in DNA sequencing highlighted at DOE Joint Genome Institute User Meeting
5. No pain, DOE Joint Genome Institute gains coveted ergonomics prize with Shake N Plate
6. Burnham Institute for Medical Research & UC San Diego establish Joint Center for Molecular Modeling
7. Joint European strategy for industrial biotechnology
8. Report highlights DOE Joint Genome Institute achievements
9. DOE Joint Genome Institute issues new call for large-scale sequencing proposals
10. Joint green chemistry meeting in Washington, D.C., features top experts on environment
11. News tips: NASA presentations at Annual 2005 Joint Assembly Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Joint Assembly Acapulco press conference schedule

(Date:8/6/2015)... 6, 2015  Today, U.S. Congressman Mike ... ™ to learn firsthand how Silicon Valley technologies ... is a world leader in multi-factor identity management ... helping federal agencies and commercial organizations achieve new ... "The vast majority of network breaches can ...
(Date:8/5/2015)... ALBANY, New York , August 5, 2015 /PRNewswire/ ... new market report titled "Facial Recognition Market - Global ... - 2022", the global market for facial recognition is ... market is driven by increased demand for surveillance systems ... to the rising number of crimes and terrorist activities ...
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
(Date:8/27/2015)... , Aug. 27, 2015 /PRNewswire/ - Portage Biotech ... PBT.U), and Biohaven Pharmaceutical Holding Company Limited (Biohaven), ... Phase I study of BHV-0223, a glutamate modulating ... regarding BHV-0223 and recently obtained clearance from the ... with human testing. Portage holds 54% equity interest ...
(Date:8/27/2015)... , August 27, 2015 GlassesOff ... image processing functions in the human vision system, announced today ... point guard Chris Paul to develop a ... who want to improve their real-life on-court performance. ... court, whether it is shooting a ball or blocking a ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet ... a second US laboratory is to open in Manhattan, Kansas in early October, ... and long-term growth of research and development through collaboration with researchers from Kansas ...
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
Breaking Biology Technology:Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
Cached News: